BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1287 related articles for article (PubMed ID: 7683923)

  • 21. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer.
    Shapiro F; Yao TJ; Raptis G; Reich L; Norton L; Moore MA
    Blood; 1994 Nov; 84(10):3567-74. PubMed ID: 7524742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M; Zhu X; Han M; Kobayashi M; Hashino S; Tanaka J; Kobayashi S; Kasai M; Asaka M
    Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects.
    Koller MR; Palsson MA; Manchel I; Palsson BO
    Blood; 1995 Sep; 86(5):1784-93. PubMed ID: 7544642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
    Möbest D; Mertelsmann R; Henschler R
    Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
    Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
    Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin.
    Brugger W; Bross K; Frisch J; Dern P; Weber B; Mertelsmann R; Kanz L
    Blood; 1992 Mar; 79(5):1193-200. PubMed ID: 1371415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells.
    Muszynski KW; Ruscetti FW; Heidecker G; Rapp U; Troppmair J; Gooya JM; Keller JR
    J Exp Med; 1995 Jun; 181(6):2189-99. PubMed ID: 7539043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
    Teofili L; Iovino MS; Di Mario A; Ortu La Barbera E; Pierelli L; Bussa S; Rumi C; Menichella G; Leone G
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():89-95. PubMed ID: 7516922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cellular basis for enhancement interactions between stem cell factor and the colony stimulating factors.
    Metcalf D
    Stem Cells; 1993 Jul; 11 Suppl 2():1-11. PubMed ID: 7691313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term effects of early-acting and multilineage hematopoietic growth factors on the repair and proliferation of irradiated pure cord blood (CB) CD34+ hematopoietic progenitor cells.
    Ziegler BL; Sandor PS; Plappert U; Thoma S; Müller R; Bock T; Thomas CA; Nothdurft W; Fliedner TM
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1193-203. PubMed ID: 9539577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic actions of stem cell factor and other burst-promoting activities on proliferation of CD34+ highly purified blood progenitors expressing HLA-DR or different levels of c-kit protein.
    Sonoda Y; Sakabe H; Ohmisono Y; Tanimukai S; Yokota S; Nakagawa S; Clark SC; Abe T
    Blood; 1994 Dec; 84(12):4099-106. PubMed ID: 7527665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin.
    Brugger W; Birken R; Bertz H; Hecht T; Pressler K; Frisch J; Schulz G; Mertelsmann R; Kanz L
    Br J Haematol; 1993 Jul; 84(3):402-7. PubMed ID: 7692928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH; Olszewski M; Kletzel M
    J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells.
    Mayani H; Dragowska W; Lansdorp PM
    Blood; 1993 Jun; 81(12):3252-8. PubMed ID: 7685200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood.
    Roecklein BA; Reems J; Rowley S; Torok-Storb B
    Biol Blood Marrow Transplant; 1998; 4(2):61-8. PubMed ID: 9763108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro expansion of human peripheral blood CD34+ cells.
    Sato N; Sawada K; Koizumi K; Tarumi T; Ieko M; Yasukouchi T; Yamaguchi M; Takahashi TA; Sekiguchi S; Koike T
    Blood; 1993 Dec; 82(12):3600-9. PubMed ID: 7505119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.
    Brugger W; Henschler R; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1994 Sep; 84(5):1421-6. PubMed ID: 7520769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.